Seksuologie pp 365-390 | Cite as

16 Seksuele disfuncties bij mannen

  • Jacques van Lankveld
  • Bert-Jan de Boer
  • Eric Meuleman
Part of the Quintessens book series (QUI)


Het terrein van de mannelijke seksuele disfuncties werd het laatste decennium gekenmerkt door snelle en zeer ingrijpende veranderingen in diagnostische en therapeutische mogelijkheden op medisch terrein


  1. 1.
    Corona G, et al. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol 2006;50(3):595–604, discussion 604.CrossRefPubMedGoogle Scholar
  2. 2.
    Bos MB, et al. De prevalentie van het metabool syndroom in Nederland: verhoogd risico op hart- en vaatziekten en diabetes mellitus type 2 bij een kwart van de personen jonger dan 60 jaar. Ned Tijdschr Geneeskd 2007;151(43):2382–8.PubMedGoogle Scholar
  3. 3.
    Sarwer DB, Durlak JA. A field trial of the effectiveness of behavioral treatment for sexual dysfunctions. J Sex Marital Ther 1997;23(2):87–97.CrossRefPubMedGoogle Scholar
  4. 4.
    Beck JG. Hypoactive sexual desire disorder: an overview. J Consult Clin Psychol 1995;63(6):919–27.CrossRefPubMedGoogle Scholar
  5. 5.
    Meuleman EJ, Van Lankveld JJ. Hypoactive sexual desire disorder: an underestimated condition in men. BJU Int 2005;95(3):291–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Simons JS, Carey MP. Prevalence of sexual dysfunctions: results from a decade of research. Arch Sex Behav 2001;30(2):177–219.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Catalan J, et al. The psychosocial impact of HIV infection in gay men. A controlled investigation and factors associated with psychiatric morbidity. Br J Psychiatry 1992;161:774–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Sandfort TG, De Keizer M. Sexual problems in gay men: an overview of empirical research. Annu Rev Sex Res 2001;12:93–120.PubMedGoogle Scholar
  9. 9.
    Everaerd W. Het psychofysiologisch laboratorium en seksuele disfunctie. Tijdschr Seksuol 2003;27:83–7.Google Scholar
  10. 10.
    Segraves KB, Segraves RT. Hypoactive sexual desire disorder: prevalence and comorbidity in 906 subjects. J Sex Marital Ther 1991;17:55–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Bozman AW, Beck JG. Covariation of sexual desire and sexual arousal: the effects of anger and anxiety. Arch Sex Behav 1991;20:47–60.CrossRefPubMedGoogle Scholar
  12. 12.
    Trudel G, Fortin C, Matte B. Sexual interaction and communication in couples with hypoactive sexual desire. Scand J Behav Ther 1997:26;49–53.CrossRefGoogle Scholar
  13. 13.
    Impett EA, et al. Maintaining sexual desire in intimate relationships: the importance of approach goals. J Pers Soc Psychol 2008;94:808–823.CrossRefPubMedGoogle Scholar
  14. 14.
    Meston CM, Buss DM. Why humans have sex. Arch Sex Behav 2007;36:477–507.CrossRefPubMedGoogle Scholar
  15. 15.
    Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. Jama 1999;281:537–44.CrossRefPubMedGoogle Scholar
  16. 16.
    Schreiner-Engel P, Schiavi RC. Lifetime psychopathology in individuals with low sexual desire. J Nerv Ment Dis; 1986:174;646–51.CrossRefPubMedGoogle Scholar
  17. 17.
    Segraves RT, Balon R. Sexual pharmacology. Fast facts. New York: Norton, 2003.Google Scholar
  18. 18.
    Bobes J, et al. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther 2003;29:125–47.CrossRefPubMedGoogle Scholar
  19. 19.
    Roney JR, Mahler SV, Maetripieri D. Behavioral and hormonal responses of men to brief interactions with women. Evol Human Behav 2003;24:365–75.CrossRefGoogle Scholar
  20. 20.
    Flynn MA, et al. Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab 1999;84:1527–33.PubMedGoogle Scholar
  21. 21.
    LoPiccolo J, Friedman JM. Broad-spectrum treatment of low sexual desire: Integration of cognitive, behavioral, and systemic therapy. In: Leiblum SR, Rosen RC, editors. Sexual desire disorders. New York: Guilford Press, 1988:107–44.Google Scholar
  22. 22.
    NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. Jama 1993;270:83–90.CrossRefGoogle Scholar
  23. 23.
    Wiegel M, Scepkowski LA, Barlow DH. Cognitiveaffective processes in sexual arousal and sexual dysfunction. In: Janssen E, editor. The psychophysiology of sex. Bloomington, IND: Indiana University Press. 2007:143–165.Google Scholar
  24. 24.
    Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol 1998;13, Suppl 6: S1–4.CrossRefPubMedGoogle Scholar
  25. 25.
    Mitchell WB, et al. Effects of positive and negative mood on sexual arousal in sexually functional males. Arch Sex Behav 1998;27:197–207.CrossRefPubMedGoogle Scholar
  26. 26.
    Masters WH, Johnson VE. Human sexual inadequacy. London: Churchill, 1970.Google Scholar
  27. 27.
    Van Lankveld JJ, Van den Hout MA, Schouten EG. The effects of self-focused attention, performance demand, and dispositional sexual self-consciousness on sexual arousal of sexually functional and dysfunctional men. Behav Res Ther 2004;42:915–35.CrossRefPubMedGoogle Scholar
  28. 28.
    Meuleman EJ, et al. Erectile dysfunction: prevalence and effect on the quality of life; Boxmeer study. Ned Tijdschr Geneeskd 2001;145:576–81.PubMedGoogle Scholar
  29. 29.
    Blanker MH, et al. Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study. J Am Geriatr Soc 2001;49:436–42.CrossRefPubMedGoogle Scholar
  30. 30.
    De Boer BJ, et al. Erectile dysfunction in primary care: prevalence and patient characteristics. The ENIGMA study. Int J Impot Res 2004;16:358–64.CrossRefPubMedGoogle Scholar
  31. 31.
    Kedde H, De Haas S. Problemen met het seksueel functioneren. In: Bakker F, Vanwesenbeeck I, editors. Seksuele gezondheid in Nederland 2006. Delft: Eburon, 2006:123–37.Google Scholar
  32. 32.
    Van Lankveld JJDM, Meuleman E. Erectiestoornissen: cognitieve gedragstherapie of farmacotherapie. In: Hengeveld MW, Brewaeys A, editors. Behandelingsstrategieën bij seksuele disfuncties. Houten/Diegem: Bohn Stafleu van Loghum, 2001:56–72.Google Scholar
  33. 33.
    Slob AK, et al. ’Leiden Impotence Screening Test’ (LIST) in men with erectile dysfunction as a preselective method prior to psychophysiological diagnostic tests. Ned Tijdschr Geneeskd 2001;145:581–6.PubMedGoogle Scholar
  34. 34.
    Speckens AE, et al. Discrimination between psychogenic and organic erectile dysfunction. J Psychosom Res 1993;37:135–45.CrossRefPubMedGoogle Scholar
  35. 35.
    Mak R, et al. Prevalence and correlates of erectile dysfunction in a population-based study in Belgium. Eur Urol 2002;41:132–8.CrossRefPubMedGoogle Scholar
  36. 36.
    Van Lankveld JJ, et al. Cognitive changes predict continued recovery of erectile functioning versus relapse after discontinuation of sildenafil treatment for male erectile dysfunction. Psychosom Med 2003; 65:709–18.CrossRefPubMedGoogle Scholar
  37. 37.
    Natali A, Olianas R, Fisch M. Penile implantation in Europe: successes and complications with 253 implants in Italy and Germany. J Sex Med 2008;5: 1503–1512.CrossRefPubMedGoogle Scholar
  38. 38.
    Meuleman EJ, et al. Disappointing long-term experiences of patients with penile prosthesis. Ned Tijdschr Geneeskd 2001;145:787–90.PubMedGoogle Scholar
  39. 39.
    Takefman J, Brender W. An analysis of the effectiveness of two components in the treatment of erectile dysfunction. Arch Sex Behav 1984;13:321–40.CrossRefPubMedGoogle Scholar
  40. 40.
    Heiman JR, Meston CM. Empirically validated treatment for sexual dysfunction. Annu Rev Sex Res 1997;8:148–94.PubMedGoogle Scholar
  41. 41.
    Van Lankveld JJ, et al. Internet-based brief sex therapy for heterosexual men with sexual dysfunctions. A randomized controlled pilot trial. J Sex Med 2009.Google Scholar
  42. 42.
    Montague DK, et al. AUA guideline on the pharmacologic management of premature ejaculation. J Urol 2004;172:290–4.CrossRefPubMedGoogle Scholar
  43. 43.
    McMahon CG, et al. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med 2008;doi:10.1111/j.1743-6109.2008.00901.x.Google Scholar
  44. 44.
    Kinsey AC, Pomeroy WR, Martin CE. Sexual behavior in the human male. Philadelphia: Saunders, 1948.Google Scholar
  45. 45.
    Waldinger MD, Schweitzer DH. The use of old and recent DSM definitions of premature ejaculation in observational studies: a contribution to the present debate for a new classification of PE in the DSM-V. J Sex Med 2008;5:1079–1087.CrossRefPubMedGoogle Scholar
  46. 46.
    Cooper AJ, Cernovsky ZZ, Colussi K. Some clinical and psychometric characteristics of primary and secondary premature ejaculators. J Sex Marital Ther 1993;19:276–88.CrossRefPubMedGoogle Scholar
  47. 47.
    Van Lankveld JJ, Grotjohann Y. Psychiatric comorbidity in heterosexual couples with sexual dysfunction assessed with the composite international diagnostic interview. Arch Sex Behav 2000;29:479–98.CrossRefPubMedGoogle Scholar
  48. 48.
    Rowland DL, et al. The psychological burden of premature ejaculation. J Urol 2007;177:1065–70.CrossRefPubMedGoogle Scholar
  49. 49.
    Waldinger MD, et al. Familial occurrence of primary premature ejaculation. Psychiatr Genet 1998;8:37–40.CrossRefPubMedGoogle Scholar
  50. 50.
    Van Lankveld JJDM, Slob AK. Voortijdig orgasme bij de man: cognitieve gedragstherapie en/of farmacotherapie. In: Hengeveld MW, Brewaeys A, editors. Behandelingsstrategieën bij seksuele disfuncties. Houten/Diegem: Bohn Stafleu van Loghum, 2001: 105–19.Google Scholar
  51. 51.
    Rowland DL, Cooper SE, Schneider M. Defining premature ejaculation for experimental and clinical investigations. Arch Sex Behav 2001;30:235–253.CrossRefPubMedGoogle Scholar
  52. 52.
    Strassberg DS, et al. Clomipramine in the treatment of rapid (premature) ejaculation. J Sex Marital Ther 1999;25:89–101.CrossRefPubMedGoogle Scholar
  53. 53.
    Abdel-Hamid IA, El Naggar EA, El Gilany A. H Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 2001;13:41–45.CrossRefPubMedGoogle Scholar
  54. 54.
    Perelman MA, Rowland DL. Retarded ejaculation. World J Urol 2006;24:645–652.CrossRefPubMedGoogle Scholar
  55. 55.
    Perelman MA, Rowland DL. Retarded and inhibited ejaculation. In: Rowland DL, Incrocci L, editors. Handbook of Sexual and Gender Identity Disorders. New York: Wiley, 2008:100–119.Google Scholar
  56. 56.
    McCabe MP. Relationship functioning and sexuality among people with multiple sclerosis. J Sex Res 2002;39:302–9.CrossRefPubMedGoogle Scholar
  57. 57.
    Sonksen J, Ohl DA. Penile vibratory stimulation and electroejaculation in the treatment of ejaculatory dysfunction. Int J Androl 2002;25:324–32.CrossRefPubMedGoogle Scholar
  58. 58.
    Montejo AL, et al. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001;62 Suppl 3:10–21.PubMedGoogle Scholar
  59. 59.
    Mah K, Binik YM. The nature of human orgasm: a critical review of major trends. Clin Psychol Rev 2001;21:823–856.CrossRefPubMedGoogle Scholar
  60. 60.
    De Bruyn JK, Van Lankveld J. Orgasmestoornissen bij de man. In: Hengeveld MW, Brewaeys A, editors. Behandelingsstrategieën bij seksuele disfuncties. Houten/Diegem: Bohn Stafleu van Loghum, 2001: 92–104.Google Scholar
  61. 61.
    Wilensky M, Myers MF. Retarded ejaculation in homosexual patients: A report of nine cases. J Sex Res 1987;13:85–91.CrossRefGoogle Scholar
  62. 62.
    Ishak WW, Berman DS, Peters A. Male anorgasmia treated with oxytocin. J Sex Med 2008;5:1022–4.CrossRefPubMedGoogle Scholar
  63. 63.
    Rosser BR, et al. Sexual difficulties, concerns, and satisfaction in homosexual men: an empirical study with implications for HIV prevention. J Sex Marital Ther 1997;23:61–73.CrossRefPubMedGoogle Scholar
  64. 64.
    Taylor FL, Levine LA. Peyronie’s Disease. Urol Clin North Am 2007;34:517–534, vi.CrossRefPubMedGoogle Scholar
  65. 65.
    Frese A, et al. Triptans in orgasmic headache. Cephalalgia 2006;26:1358–1361.CrossRefGoogle Scholar
  66. 66.
    Valenca MM, et al. Cerebral vasospasm and headache during sexual intercourse and masturbatory orgasms. Headache 2004;44:224–228.CrossRefGoogle Scholar
  67. 67.
    Hengeveld MW, Gianotten WL. Erectile disorders: the reality. Ned Tijdschr Geneeskd 2001;145:1381–4.PubMedGoogle Scholar
  68. 68.
    De Boer BJ, Lycklama à Nijeholt AAB et al. Intracaverneuze auto-injectietherapie met papaverine-fentolamine via een auto-injectiepen bij patiënten met een erectiestoornis: vergelijkbare resultaten bij huisarts en uroloog. Ned Tijdschr Geneeskd 2001; 145:783–7.PubMedGoogle Scholar

Copyright information

© Bohn Stafleu van Loghum, onderdeel van Springer Uitgeverij 2009

Authors and Affiliations

  • Jacques van Lankveld
  • Bert-Jan de Boer
  • Eric Meuleman

There are no affiliations available

Personalised recommendations